Abstract
HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have